March 19, 2018 / 10:46 AM / 8 months ago

BRIEF-Ritter Pharmaceuticals Reports Q4 Loss Per Share $0.11

March 19 (Reuters) - Ritter Pharmaceuticals Inc:

* RITTER PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.11

* ‍ ON TRACK TO START SCREENING IN Q2​ FOR FIRST PIVOTAL PHASE 3 CLINICAL TRIAL OF RP-G28 IN LACTOSE INTOLERANCE

* ‍ AS OF DECEMBER 31, 2017, HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $22.6 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below